Your browser doesn't support javascript.
loading
Silymarin mitigates bile duct obstruction-induced cholemic nephropathy.
Ommati, Mohammad Mehdi; Farshad, Omid; Azarpira, Negar; Ghazanfari, Elmira; Niknahad, Hossein; Heidari, Reza.
Affiliation
  • Ommati MM; College of Life Sciences, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
  • Farshad O; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Azarpira N; Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 158371345, Roknabad, Karafarin St., Shiraz, Fars, Iran.
  • Ghazanfari E; Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Niknahad H; Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 158371345, Roknabad, Karafarin St., Shiraz, Fars, Iran.
  • Heidari R; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. niknahadh@sums.ac.ir.
Naunyn Schmiedebergs Arch Pharmacol ; 394(6): 1301-1314, 2021 06.
Article in En | MEDLINE | ID: mdl-33538845

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Silymarin / Cholestasis / Kidney Diseases / Antioxidants Type of study: Etiology_studies Limits: Animals Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2021 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Silymarin / Cholestasis / Kidney Diseases / Antioxidants Type of study: Etiology_studies Limits: Animals Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2021 Type: Article Affiliation country: China